G K Lau

Summary

Affiliation: The Chinese University of Hong Kong
Country: China

Publications

  1. pmc Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong
    J Clin Pathol 50:706-8. 1997
  2. ncbi request reprint Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong
    J Hepatol 28:359-68. 1998
  3. ncbi request reprint Histological changes of concurrent hepatitis C virus infection in asymptomatic hepatitis B virus patients
    G K Lau
    Department of Medicine, The University of Hong Kong, Hong Kong
    J Gastroenterol Hepatol 13:52-6. 1998
  4. ncbi request reprint Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    J Gastroenterol Hepatol 14:3-12. 1999
  5. ncbi request reprint Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    J Gastroenterol Hepatol 14:262-8. 1999
  6. ncbi request reprint Hepatitis B infection in China
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong, SAR, China
    Clin Liver Dis 5:361-79. 2001
  7. ncbi request reprint Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
    J Gastroenterol Hepatol 15:E46-52. 2000
  8. ncbi request reprint Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong, China
    Hepatology 32:394-9. 2000
  9. ncbi request reprint One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance
    B C Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    Aliment Pharmacol Ther 15:403-9. 2001
  10. ncbi request reprint An evaluation of whole blood testing for Helicobacter pylori infection in the Chinese population
    B C Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong S A R, China
    Aliment Pharmacol Ther 14:331-5. 2000

Detail Information

Publications18

  1. pmc Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong
    J Clin Pathol 50:706-8. 1997
    ..However, the degree of fibrosis, though mild, remained the same. With the serological clearance of hepatitis B surface antigen, a small amount of hepatitis B virus DNA was still detectable in the nuclei of liver cells...
  2. ncbi request reprint Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong
    J Hepatol 28:359-68. 1998
    ..We have studied the effect of famciclovir on the incidence of hepatitis B virus reactivation and hepatitis after allogeneic bone marrow transplantation...
  3. ncbi request reprint Histological changes of concurrent hepatitis C virus infection in asymptomatic hepatitis B virus patients
    G K Lau
    Department of Medicine, The University of Hong Kong, Hong Kong
    J Gastroenterol Hepatol 13:52-6. 1998
    ..These findings suggest that hepatitis C coinfection in asymptomatic chronic hepatitis B patients is uncommon in Hong Kong Chinese and active hepatitis B viral replication is absent in these patients...
  4. ncbi request reprint Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    J Gastroenterol Hepatol 14:3-12. 1999
    ..The future direction of therapy in chronic hepatitis B infection is probably a combination of nucleoside analogues or nucleoside analogues with immunomodulatory therapy...
  5. ncbi request reprint Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer
    G K Lau
    Department of Medicine, Queen Mary Hospital, Hong Kong, China
    J Gastroenterol Hepatol 14:262-8. 1999
    ..Histological changes during the clearance of HBsAg are unknown...
  6. ncbi request reprint Hepatitis B infection in China
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong, SAR, China
    Clin Liver Dis 5:361-79. 2001
    ..Also, the use of lamivudine to prevent HBV reactivation on withdrawal of immunosuppressive therapy should be explored...
  7. ncbi request reprint Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China
    J Gastroenterol Hepatol 15:E46-52. 2000
    ..In the future, it is likely that different types of combination therapy may have to be tailor-made for chronic HBV infection with different virological and immunological profiles and different degrees of liver damage...
  8. ncbi request reprint Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study
    G K Lau
    University Department of Medicine, Queen Mary Hospital, Hong Kong, China
    Hepatology 32:394-9. 2000
    ..Further studies of longer duration are needed to define whether combination therapy will increase the HBeAg seroconversion rate and decrease the rate of emergence of lamivudine-resistant variants...
  9. ncbi request reprint One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance
    B C Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    Aliment Pharmacol Ther 15:403-9. 2001
    ..To compare 1-week ranitidine bismuth citrate-based (RBC) triple therapy vs. omeprazole-based (O) triple therapy for the eradication of Helicobacter pylori infection in Hong Kong with high prevalence of metronidazole resistance...
  10. ncbi request reprint An evaluation of whole blood testing for Helicobacter pylori infection in the Chinese population
    B C Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong S A R, China
    Aliment Pharmacol Ther 14:331-5. 2000
    ..Near patient tests for Helicobacter pylori were developed to assist in the management of dyspepsia patients in general practice. Most studies were performed in western populations...
  11. ncbi request reprint Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management
    L Xunrong
    University Department of Medicine, Queen Mary Hospital, 102 Pokfulum Road, Hong Kong SAR, China
    Rev Med Virol 11:287-99. 2001
    ..Further controlled studies are needed to define the incidence and risk factors of hepatitis B reactivation so that pre-emptive treatment with nucleoside analogues could be administered to those patients at high risk of disease...
  12. ncbi request reprint Evaluation of a new referral system for the management of dyspepsia in Hong Kong: role of open-access upper endoscopy
    B C Wong
    Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    J Gastroenterol Hepatol 15:1251-6. 2000
    ..A study on the outcome of open-access upper endoscopy in contrast with the conventional referral system was conducted...
  13. ncbi request reprint Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem
    R Liang
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    J Clin Oncol 17:394-8. 1999
    ..It is recommended that all cancer patients be checked for their hepatitis B status before receiving chemotherapy or a bone marrow transplant, especially if they reside in or come from endemic areas of HBV infection...
  14. ncbi request reprint Efficacy of a pre-S containing vaccine in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B
    C M Lo
    Centre for the Study of Liver Disease, The University of Hong Kong, Pokfulam, Hong Kong, China
    Am J Transplant 7:434-9. 2007
    ..At the end of the study, all patients remained seronegative for HBsAg. In conclusion, Sci-B-Vac is effective in about 50% of patients receiving lamividine prophylaxis and may prevent recurrence due to escape mutants...
  15. ncbi request reprint Aggressive hepatocellular carcinoma complicating pregnancy after autologous bone marrow transplantation for non-Hodgkin's lymphoma
    W Y Au
    Department of Medicine, Queen Mary Hospital, Hong Kong
    Bone Marrow Transplant 29:177-9. 2002
    ..Biochemical and radiological surveillance for HCC should be strengthened in HBV carriers after BMT, especially in patients with the histology of chronic liver disease, or biochemical/ virological evidence of increased HBV activity...
  16. ncbi request reprint Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation
    S Y Ma
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    Bone Marrow Transplant 34:57-61. 2004
    ..001) and gut (0/11 vs 28/106, P<0.001) involvement. However, liver GVHD post-DLI and post-HSCT had comparable patient characteristics, underlying diseases, clinical subtypes (classical and hepatitic) and response to treatment...
  17. ncbi request reprint Disease progression in Chinese chronic hepatitis C patients with persistently normal alanine aminotransaminase levels
    C K Hui
    Department of Medicine, Queen Mary Hospital, and Research Centre of Infection and Immunity, The University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China
    Aliment Pharmacol Ther 25:1283-92. 2007
    ..However, it is uncertain which group of patients is at risk of disease progression...
  18. ncbi request reprint Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study
    B C Wong
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    Aliment Pharmacol Ther 15:843-9. 2001
    ..To compare the efficacy and tolerability of a 3-day quadruple therapy with a standard 7-day triple therapy in eradicating Helicobacter pylori infection and healing duodenal ulcers...